News
Amid high inflation and economic uncertainty, Chili's value proposition and strong revenue growth make it an attractive buy, ...
The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...
Researchers at the Manchester Institute of Biotechnology (MIB) have demonstrated how genetically engineered enzymes can ...
What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...
These biotech companies are among the first to break even or reach that point in 2025. But their winning formulas are similar – steady sales growth both at home and abroad, development of a robust ...
His ousting of Peter Marks—a senior official at the Food and Drug Administration and key proponent of faster drug approvals—sent biotech stocks tumbling last month and stoked concerns that the ...
BUENOS AIRES--(BUSINESS WIRE)--GridX, Latin America's largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative startups across ...
As the world enters an age of biotechnology, there is emerging evidence that China is “distorting” biotechnology markets and is quickly ascending to “dominance” in this field, having made ...
One relatively small biotech company has made a breakthrough that could be used to treat a range of cancer. While it's been a poor performer for the past few years despite promising growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results